Bayer Aktiengesellschaft (BAYRY)
| Market Cap | 26.37B |
| Revenue (ttm) | 50.48B |
| Net Income (ttm) | -1.36B |
| Shares Out | n/a |
| EPS (ttm) | -1.38 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.02 (0.32%) |
| Ex-Dividend Date | Apr 29, 2024 |
| Volume | 540,197 |
| Open | 6.50 |
| Previous Close | 6.77 |
| Day's Range | 6.39 - 6.50 |
| 52-Week Range | 6.39 - 11.33 |
| Beta | 0.97 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 12, 2024 |
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical product... [Read more]
News
Bayer and Liveo Research Launch First-of-its-Kind Blister Packaging with Improved Environmental Footprint
BASEL, Switzerland--(BUSINESS WIRE)--Bayer has launched a first-of-its-kind in the healthcare industry, polyethylene terephthalate (PET) blister packaging on its renowned brand, Aleve. Realized in par...
Bayer submits EU marketing application for menopause relief drug
Bayer on Tuesday said it had applied for marketing authorization with the European Medicines Agency (EMA) for its menopause relief drug elinzanetant.
Bayer Seeks European Approval For Third Indication For Cancer Drug Darolutamide
On Monday, Bayer AG (OTC: BAYRY) submitted an application to the European Medicines Agency (EMA) for the oral androgen receptor inhibitor (ARi) darolutamide. Bayer is seeking approval for the use of ...
Bayer applies for third indication of Nubeqa in EU
Bayer said on Monday that it has applied to the EU's drugs regulator for the use of Nubeqa, also known as darolutamide, in combination with androgen deprivation therapy.
Orion's collaboration partner Bayer submits application for third indication of darolutamide in the EU
ORION CORPORATION INVESTOR NEWS 14 OCTOBER 2024 at 11.00 EEST Orion's collaboration partner Bayer submits application for third indication of darolutamide in the EU Orion's collaboration part...
Bayer must pay $78 mln in latest Roundup cancer trial, jury finds
Bayer must pay $78 million to a Pennsylvania man who said he got cancer from using the company's Roundup weedkiller, a state court jury in Philadelphia found on Thursday.
Bayer shares fall 7% as US court reconsiders Monsanto PCB exposure case
German life sciences giant Bayer saw its shares drop by over 7% on Wednesday following a US court's decision to review a case against Monsanto, a subsidiary acquired by Bayer in 2018. The litigation i...
Bayer plunges after U.S. court accepts review of Washington PCB case
Bayer shares drop after state of Washington's top court said it will review Monsanto case alleging harm from toxic chemicals at school.
Bayer Shares Plunge After U.S. Legal Setback
Washington state’s top court granted a petition for review in a case over allegations of contamination against Bayer’s Monsanto.
Bayer Shares Plunge After U.S. Legal Setback
Washington state's top court granted a petition for review in a case over allegations of contamination against Bayer's Monsanto.
Bayer shares down 7% after U.S. court says it will review Monsanto case
The company said in a statement Wednesday that there was "no basis for a different outcome on appeal."
U.S. Food and Drug Administration (FDA) accepts New Drug Application for elinzanetant
The New Drug Application (NDA) for elinzanetant, an investigational compound for the treatment of moderate to severe vasomotor symptoms associated with menopause, is based on the positive data from th...
Bayer Shares Drop After PCB Case Gets US Court Review
Bayer AG shares fell after Washington state’s top court said it will review a case against its Monsanto unit over allegations that exposure to the firm’s toxic chemicals caused brain injuries to three...
CK Life’s new CEO counts on Big Pharma experience to boost new drug success, earnings
Lance Yuen spent two decades at Bristol-Myers Squibb and Bayer in the region before becoming the CEO at CK Life Sciences last month.
Bayer and MOMA Therapeutics Enter Collaboration and License Agreement in Oncology
BERLIN & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bayer and MOMA Therapeutics, Inc., a clinical-stage biopharmaceutical company discovering and developing a new generation of precision therapeutics, today a...
Google DeepMind exec shares what the company uses AI for 'big time'
Google DeepMind is utilizing its Gemini AI model to manage up to 50% of legal information requests, significantly boosting efficiency. Similarly, Bayer's pharmaceuticals division uses AI for 70% to 80...
Bayer clinches Guinness World Record for most cardiovascular disease screenings in 12 hours
This significant milestone comes as a part of Bayers continuous efforts to raise awareness about the importance of cardiovascular disease screenings and early detection
Bayer Submits Supplemental New Drug Application to U.S. FDA Seeking Expanded Indication for NUBEQA® (darolutamide) in Metastatic Hormone-Sensitive Prostate Cancer
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced the submission of a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) for the oral androgen receptor inhibi...
Orion's collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbuster
ORION CORPORATION INVESTOR NEWS 26 SEPTEMBER 2024 at 11.00 EEST Orion's collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the f...
Bayer, UPMC Magee-Women's Hospital, PA Senate President Pro Tempore Kim Ward Collaborate to Bring Breast Health Care and Awareness to Pittsburgh Region's Rural and Underserved Communities
PITTSBURGH--(BUSINESS WIRE)--Bayer, UPMC Magee-Womens Hospital and Pennsylvania State Senator Kim Ward (R-Westmoreland County) are collaborating to address the health access gaps that disproportionall...
Celebrating America's Farmers: Luke Bryan Honors Those Who Feed Us
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- According to Feeding America's latest data, more than 47 million people in the United States are food insecure 1 , a nearly 30% increase – more than 10 mil...
Bayer Targets Expanded Use Approval For Prostate Cancer Drug, Reveals Encouraging Data From Pivotal Study
On Monday, Bayer AG (OTC: BAYRY) said results from the Phase 3 ARANOTE trial have shown that darolutamide plus androgen deprivation therapy (ADT) significantly reduced the risk of radiological progre...
Roundup Lawsuits Pose a Threat to My Missouri Farm
Bayer has already pulled the herbicide from the consumer market based on false cancer claims.
Abu Dhabi plans $15.9 billion offer for German chemicals giant Covestro: report
Abu Dhabi National Oil Company is expected to make an offer to buy the Bayer spinoff in what would mark the largest cash transaction in the history of the chemicals industry
Roivant Sciences Unveils New 'Vant' Subsidiary For In-Licensed Pulmonary Hypertension Drug From Bayer
Tuesday, Roivant Sciences Ltd. (NASDAQ: ROIV) created Pulmovant to in-license from Bayer AG (OTC: BAYRY) exclusive worldwide rights to develop and commercialize mosliciguat . Bayer received an upfro...